Eficacitatea tratamentului antiviral &icirc;n hepatita cronică virală C

Pântea Victor; Plăcintă Gheorghe; Cojuhari Lilia; Cebotarescu Valentin; Iarovoi Liviu; Melnicenco Olesea; Tolmaci Tatiana; Culiuc Natalia

Conţinutul numărului revistei

Articolul precedent

Articolul urmator

588

Ultima descărcare din IBN:
2022-07-18 18:05

SM ISO690:2012

PÂNTEA, Victor, PLĂCINTĂ, Gheorghe, COJUHARI, Lilia, CEBOTARESCU, Valentin, IAROVOI, Liviu, MELNICENCO, Olesea, TOLMACI, Tatiana, CULIUC, Natalia. Eficacitatea tratamentului antiviral în hepatita cronică virală C. In: Sănătate Publică, Economie şi Management în Medicină , 2013, nr. 5(50), pp. 137-139. ISSN 1729-8687.

EXPORT metadate:
Google Scholar
Crossref
CERIF

DataCite
Dublin Core

Sănătate Publică, Economie şi Management în Medicină

Numărul 5(50) / 2013 / ISSN 1729-8687 /ISSNe 2587-3873

Eficacitatea tratamentului antiviral în hepatita cronică virală C

Efficacy of antiviral therapy in chronic hepatitis C

Эффективность противовирусной терапии хронического гепатита С

Pag. 137-139

Pântea Victor¹, Plăcintă Gheorghe¹, Cojuhari Lilia¹, Cebotarescu Valentin¹, Iarovoi Liviu¹, Melnicenco Olesea¹, Tolmaci Tatiana², Culiuc Natalia²

¹ Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu“,
² Spitalul Clinic Republican de Boli Infecţioase „Toma Ciorbă“

Disponibil în IBN: 15 februarie 2020

Descarcă PDF

Rezumat

Hepatitis C virus is a major public health problem. There were examined 61 patients with chronic hepatitis C hospitalized to “Toma Ciorba” IDCH. These patients treated with Pegasys+Copegus. For treatment effi ciency assessment were estimated the following examination results: clinical, biochemical, immunological and PCR. The obtained results analysis show that this treatment method is effi cient and can be recommended in viral C hepatitis treatment.

Вирусный гепатит C является одной из основных проблем современного здравоохранения. Было обследовано 61 больных хроническим вирусным гепатитом С, госпитализированных в ИКБ «Тома Чорбэ». Эти больные прошли курс лечения препаратами Пегасис+Копегус. Для оценки эффективности лечения оценены: клинические, биохимические, иммунологические и молекулярнобиологические результаты. Анализ полученных результатов позволяет сделать вывод о том, что предпринятый метод лечения эффективен в терапии вирусного гепатита С.

Cuvinte-cheie
hepatitis C, antiviral treatment, Pegasys, Copegus,

гепатит С, противовирусное лечение, Пегасис, Копегус

Cerif XML Export

<?xml version='1.0' encoding='utf-8'?>
<CERIF xmlns='urn:xmlns:org:eurocris:cerif-1.5-1' xsi:schemaLocation='urn:xmlns:org:eurocris:cerif-1.5-1 http://www.eurocris.org/Uploads/Web%20pages/CERIF-1.5/CERIF_1.5_1.xsd' xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' release='1.5' date='2012-10-07' sourceDatabase='Output Profile'>
<cfResPubl>
<cfResPublId>ibn-ResPubl-95429</cfResPublId>
<cfResPublDate>2013-10-01</cfResPublDate>
<cfVol>50</cfVol>
<cfIssue>5</cfIssue>
<cfStartPage>137</cfStartPage>
<cfISSN>1729-8687</cfISSN>
<cfURI>https://ibn.idsi.md/ro/vizualizare_articol/95429</cfURI>
<cfTitle cfLangCode='RO' cfTrans='o'>Eficacitatea tratamentului antiviral &icirc;n hepatita cronică virală C</cfTitle>
<cfKeyw cfLangCode='RO' cfTrans='o'>hepatitis C; antiviral treatment; Pegasys; Copegus; гепатит С; противовирусное лечение; Пегасис; Копегус</cfKeyw>
<cfAbstr cfLangCode='EN' cfTrans='o'><p>Hepatitis C virus is a major public health problem. There were examined 61 patients with chronic hepatitis C hospitalized to &ldquo;Toma Ciorba&rdquo; IDCH. These patients treated with Pegasys+Copegus. For treatment effi ciency assessment were estimated the following examination results: clinical, biochemical, immunological and PCR. The obtained results analysis show that this treatment method is effi cient and can be recommended in viral C hepatitis treatment.</p></cfAbstr>
<cfAbstr cfLangCode='RU' cfTrans='o'><p>Вирусный гепатит C является одной из основных проблем современного здравоохранения. Было обследовано 61 больных хроническим вирусным гепатитом С, госпитализированных в ИКБ &laquo;Тома Чорбэ&raquo;. Эти больные прошли курс лечения препаратами Пегасис+Копегус. Для оценки эффективности лечения оценены: клинические, биохимические, иммунологические и молекулярнобиологические результаты. Анализ полученных результатов позволяет сделать вывод о том, что предпринятый метод лечения эффективен в терапии вирусного гепатита С.</p></cfAbstr>
<cfResPubl_Class>
<cfClassId>eda2d9e9-34c5-11e1-b86c-0800200c9a66</cfClassId>
<cfClassSchemeId>759af938-34ae-11e1-b86c-0800200c9a66</cfClassSchemeId>
<cfStartDate>2013-10-01T24:00:00</cfStartDate>
</cfResPubl_Class>
<cfResPubl_Class>
<cfClassId>e601872f-4b7e-4d88-929f-7df027b226c9</cfClassId>
<cfClassSchemeId>40e90e2f-446d-460a-98e5-5dce57550c48</cfClassSchemeId>
<cfStartDate>2013-10-01T24:00:00</cfStartDate>
</cfResPubl_Class>
<cfPers_ResPubl>
<cfPersId>ibn-person-11460</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2013-10-01T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-11476</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2013-10-01T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-10995</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2013-10-01T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-10924</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2013-10-01T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-11184</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2013-10-01T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-13084</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2013-10-01T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-72666</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2013-10-01T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-34060</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2013-10-01T24:00:00</cfStartDate>
</cfPers_ResPubl>
</cfResPubl>
<cfPers>
<cfPersId>ibn-Pers-11460</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-11460-2</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2013-10-01T24:00:00</cfStartDate>
<cfFamilyNames>Pântea</cfFamilyNames>
<cfFirstNames>Victor</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-11476</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-11476-2</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2013-10-01T24:00:00</cfStartDate>
<cfFamilyNames>Plăcintă</cfFamilyNames>
<cfFirstNames>Gheorghe</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-10995</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-10995-2</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2013-10-01T24:00:00</cfStartDate>
<cfFamilyNames>Cojuhari</cfFamilyNames>
<cfFirstNames>Lilia</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-10924</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-10924-2</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2013-10-01T24:00:00</cfStartDate>
<cfFamilyNames>Cebotarescu</cfFamilyNames>
<cfFirstNames>Valentin</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-11184</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-11184-2</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2013-10-01T24:00:00</cfStartDate>
<cfFamilyNames>Iarovoi</cfFamilyNames>
<cfFirstNames>Liviu</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-13084</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-13084-2</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2013-10-01T24:00:00</cfStartDate>
<cfFamilyNames>Melnicenco</cfFamilyNames>
<cfFirstNames>Olesea</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-72666</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-72666-2</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2013-10-01T24:00:00</cfStartDate>
<cfFamilyNames>Tolmaci</cfFamilyNames>
<cfFirstNames>Tatiana</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-34060</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-34060-2</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2013-10-01T24:00:00</cfStartDate>
<cfFamilyNames>Culiuc</cfFamilyNames>
<cfFirstNames>Natalia</cfFirstNames>
</cfPersName_Pers>
</cfPers>
</CERIF>